Inventor profile of:

Manuel Baca

City:

Gaithersburg, Maryland

Country:

United States

Published Applications:

30

Last publication date:

2025-02-13

Top Assignees for applications by Manuel Baca

The entities that hold a legal rights for patent applications filed by inventor Baca Manuel:

Recent patent applications by Baca Manuel

Manuel Baca from Gaithersburg, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-02-13
US20250051462A1
Chemistry; metallurgy

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

#2 | 2022-03-24
US20220089688A1
Chemistry; metallurgy

Methods of administering a composition comprising a Tn3 scaffold and a CD40L-specific monomer

#3 | 2021-08-26
US20210260159A1
Human necessities

CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

#4 | 2021-08-19
US20210254024A1
Chemistry; metallurgy

URICASE SEQUENCES AND METHODS OF TREATMENT

#5 | 2021-01-14
US20210009701A1
Chemistry; metallurgy

Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein

#6 | 2019-02-21
US20190055313A1
Chemistry; metallurgy

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

#7 | 2019-02-14
US20190048327A1
Chemistry; metallurgy

Uricase sequences and methods of treatment

#8 | 2018-09-13
US20180258406A1
Chemistry; metallurgy

Uricase sequences and methods of treatment

#9 | 2017-12-28
US20170369579A1
Chemistry; metallurgy

High affinity antibody antagonists of interleukin-13 receptor alpha 1

#10 | 2017-12-28
US20170369564A1
Chemistry; metallurgy

ANTI-VEGF ANTIBODIES

#11 | 2017-11-16
US20170327588A1
Chemistry; metallurgy

CD40L-Fc fusion polypeptides and methods of use thereof

#12 | 2017-08-10
US20170226214A1
Chemistry; metallurgy

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

#13 | 2016-12-15
US20160362497A1
Chemistry; metallurgy

High affinity antibody antagonists of interleukin-13 receptor alpha 1

#14 | 2016-09-08
US20160257738A1
Chemistry; metallurgy

ANTI-VEGF ANTIBODIES

#15 | 2016-02-04
US20160031998A1
Chemistry; metallurgy

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

#16 | 2015-04-09
US20150098955A1
Chemistry; metallurgy

CD40L-specific TN3-derived scaffolds and methods of use thereof

#17 | 2015-01-22
US20150023951A1
Chemistry; metallurgy

ANTI-VEGF ANTIBODIES

#18 | 2014-05-22
US20140141994A1
Physics

Protein scaffolds

#19 | 2014-02-27
US20140056915A1
Chemistry; metallurgy

High affinity antibody antagonists of interleukin-13 receptor alpha 1

#20 | 2013-04-18
US20130096058A1
Chemistry; metallurgy

TRAIL R2-specific multimeric scaffolds

#21 | 2013-03-28
US20130079280A1
Chemistry; metallurgy

FIBRONECTIN TYPE III DOMAIN-BASED MULTIMERIC SCAFFOLDS

#22 | 2013-03-07
US20130058927A1
Chemistry; metallurgy

ANTI-VEGF ANTIBODIES

#23 | 2012-12-20
US20120321630A1
Chemistry; metallurgy

Antibodies against G-CSFR and uses thereof

#24 | 2011-12-08
US20110300100A1
Chemistry; metallurgy

IL-11 muteins

#25 | 2011-03-03
US20110052597A1
Chemistry; metallurgy

Anti-IL-13Rα1 antibodies and their uses thereof

#26 | 2010-11-25
US20100298541A1
Physics

Protein scaffolds

#27 | 2010-11-11
US20100285035A1
Chemistry; metallurgy

High affinity antibody antagonists of interleukin-13 receptor alpha 1

#28 | 2009-08-13
US20090202533A1
Human necessities

Methods of treating inflammatory airway conditions by inhibition of IL-11 activity

#29 | 2009-07-30
US20090191148A1
Chemistry; metallurgy

IL-11 muteins

#30 | 2008-07-10
US20080166343A1
Chemistry; metallurgy

High affinity antibody antagonists of interleukin-13 receptor alpha 1

InventorID:

126852 āŽ˜